David Happel owns 1.19% of Sagimet Biosciences
741,570 shares as of the July 20, 2026 filing, worth $5.9M at the latest close.
SGMT · $499M market capGet an email when David Happel’s stake moves.
Free.
The stake
1.19%
worth $5.9M at the latest close
Stake rank
#2,033
by dollar value of the stake
Last sale
91 days ago
Jul 20, 2026
Last buy
937 days ago
Mar 26, 2024 · $63,731
David Happel owns 1.19% of Sagimet Biosciences Inc.: 741,570 of 62,158,653 shares, worth about $5.9M at the 2026-10-16 close. The stake has moved from 0.00% in 2023 to 1.19% on 2026-07-20, across 3 sales and 3 purchases that moved it since 2016. The last trade that moved it was a discretionary sale of $497,068 on 2026-07-20.
How the stake is held
as of the Jul 20, 2026 filing
SHARES
OF THE STAKE
SERIES A · stated Jul 20, 2026 · Form 4 ↗
HELD DIRECTLY
741,570
100.0%
THE STAKE
741,570
1.19%